nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP2E1—Fingolimod—multiple sclerosis	0.104	0.163	CbGbCtD
Mitoxantrone—ABCG2—Cladribine—multiple sclerosis	0.0936	0.147	CbGbCtD
Mitoxantrone—CYP1B1—Dexamethasone—multiple sclerosis	0.0745	0.117	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—multiple sclerosis	0.0425	0.0667	CbGbCtD
Mitoxantrone—ABCG2—Dexamethasone—multiple sclerosis	0.0354	0.0556	CbGbCtD
Mitoxantrone—ABCB1—Methylprednisolone—multiple sclerosis	0.0338	0.053	CbGbCtD
Mitoxantrone—CYP3A4—Fingolimod—multiple sclerosis	0.0314	0.0493	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—multiple sclerosis	0.0285	0.0447	CbGbCtD
Mitoxantrone—CYP2E1—Dexamethasone—multiple sclerosis	0.0252	0.0396	CbGbCtD
Mitoxantrone—ABCB1—Betamethasone—multiple sclerosis	0.0219	0.0345	CbGbCtD
Mitoxantrone—ABCB1—Prednisolone—multiple sclerosis	0.0217	0.034	CbGbCtD
Mitoxantrone—ABCB1—Prednisone—multiple sclerosis	0.0204	0.0321	CbGbCtD
Mitoxantrone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0202	0.0317	CbGbCtD
Mitoxantrone—CYP3A4—Triamcinolone—multiple sclerosis	0.0153	0.0241	CbGbCtD
Mitoxantrone—CYP3A4—Betamethasone—multiple sclerosis	0.0131	0.0206	CbGbCtD
Mitoxantrone—CYP3A4—Prednisolone—multiple sclerosis	0.013	0.0204	CbGbCtD
Mitoxantrone—ABCB1—Dexamethasone—multiple sclerosis	0.0128	0.02	CbGbCtD
Mitoxantrone—CYP3A4—Prednisone—multiple sclerosis	0.0123	0.0192	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—multiple sclerosis	0.0103	0.0161	CbGbCtD
Mitoxantrone—CYP3A4—Dexamethasone—multiple sclerosis	0.00765	0.012	CbGbCtD
Mitoxantrone—BTK—medulla oblongata—multiple sclerosis	0.00203	0.0577	CbGeAlD
Mitoxantrone—SLC47A2—nervous system—multiple sclerosis	0.00203	0.0575	CbGeAlD
Mitoxantrone—SLC47A2—central nervous system—multiple sclerosis	0.00195	0.0553	CbGeAlD
Mitoxantrone—BTK—spinal cord—multiple sclerosis	0.00181	0.0514	CbGeAlD
Mitoxantrone—PIM1—medulla oblongata—multiple sclerosis	0.00176	0.05	CbGeAlD
Mitoxantrone—PIM1—midbrain—multiple sclerosis	0.00161	0.0457	CbGeAlD
Mitoxantrone—PIM1—spinal cord—multiple sclerosis	0.00157	0.0446	CbGeAlD
Mitoxantrone—SLC47A2—brain—multiple sclerosis	0.00155	0.0439	CbGeAlD
Mitoxantrone—SLC47A1—brainstem—multiple sclerosis	0.00135	0.0384	CbGeAlD
Mitoxantrone—PIM1—nervous system—multiple sclerosis	0.00132	0.0375	CbGeAlD
Mitoxantrone—PIM1—central nervous system—multiple sclerosis	0.00127	0.0361	CbGeAlD
Mitoxantrone—PIM1—cerebellum—multiple sclerosis	0.00125	0.0353	CbGeAlD
Mitoxantrone—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.0012	0.378	CbGdCrCtD
Mitoxantrone—BTK—brain—multiple sclerosis	0.00117	0.0331	CbGeAlD
Mitoxantrone—PIM1—brain—multiple sclerosis	0.00101	0.0287	CbGeAlD
Mitoxantrone—SLC47A1—medulla oblongata—multiple sclerosis	0.000944	0.0268	CbGeAlD
Mitoxantrone—SLC47A1—spinal cord—multiple sclerosis	0.000842	0.0239	CbGeAlD
Mitoxantrone—TOP2A—Clofarabine—Cladribine—multiple sclerosis	0.000841	0.265	CbGdCrCtD
Mitoxantrone—SLC47A1—nervous system—multiple sclerosis	0.000709	0.0201	CbGeAlD
Mitoxantrone—SLC47A1—central nervous system—multiple sclerosis	0.000683	0.0194	CbGeAlD
Mitoxantrone—SLC47A1—cerebellum—multiple sclerosis	0.000667	0.0189	CbGeAlD
Mitoxantrone—SLC47A1—brain—multiple sclerosis	0.000542	0.0154	CbGeAlD
Mitoxantrone—CYP1B1—nervous system—multiple sclerosis	0.00052	0.0147	CbGeAlD
Mitoxantrone—ABCG2—medulla oblongata—multiple sclerosis	0.000515	0.0146	CbGeAlD
Mitoxantrone—TOP2A—Azacitidine—Cladribine—multiple sclerosis	0.000513	0.161	CbGdCrCtD
Mitoxantrone—CYP1B1—central nervous system—multiple sclerosis	0.000501	0.0142	CbGeAlD
Mitoxantrone—CYP1B1—cerebellum—multiple sclerosis	0.000489	0.0139	CbGeAlD
Mitoxantrone—ABCG2—midbrain—multiple sclerosis	0.000471	0.0134	CbGeAlD
Mitoxantrone—ABCG2—spinal cord—multiple sclerosis	0.000459	0.013	CbGeAlD
Mitoxantrone—CYP2E1—medulla oblongata—multiple sclerosis	0.000446	0.0127	CbGeAlD
Mitoxantrone—ABCC1—cerebellum—multiple sclerosis	0.00044	0.0125	CbGeAlD
Mitoxantrone—CYP2E1—spinal cord—multiple sclerosis	0.000398	0.0113	CbGeAlD
Mitoxantrone—CYP1B1—brain—multiple sclerosis	0.000397	0.0113	CbGeAlD
Mitoxantrone—ABCG2—cerebellum—multiple sclerosis	0.000364	0.0103	CbGeAlD
Mitoxantrone—ABCC1—brain—multiple sclerosis	0.000357	0.0101	CbGeAlD
Mitoxantrone—ABCB1—retina—multiple sclerosis	0.000352	0.00997	CbGeAlD
Mitoxantrone—CYP2E1—nervous system—multiple sclerosis	0.000335	0.00951	CbGeAlD
Mitoxantrone—CYP2E1—central nervous system—multiple sclerosis	0.000323	0.00915	CbGeAlD
Mitoxantrone—CYP2E1—cerebellum—multiple sclerosis	0.000315	0.00895	CbGeAlD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	0.000314	0.0989	CbGdCrCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	0.000307	0.0966	CbGdCrCtD
Mitoxantrone—ABCG2—brain—multiple sclerosis	0.000296	0.00839	CbGeAlD
Mitoxantrone—CYP3A4—nervous system—multiple sclerosis	0.00027	0.00765	CbGeAlD
Mitoxantrone—CYP3A4—central nervous system—multiple sclerosis	0.00026	0.00736	CbGeAlD
Mitoxantrone—CYP2E1—brain—multiple sclerosis	0.000256	0.00727	CbGeAlD
Mitoxantrone—ABCB1—medulla oblongata—multiple sclerosis	0.000254	0.00721	CbGeAlD
Mitoxantrone—ABCB1—midbrain—multiple sclerosis	0.000232	0.00659	CbGeAlD
Mitoxantrone—ABCB1—spinal cord—multiple sclerosis	0.000227	0.00643	CbGeAlD
Mitoxantrone—Haemorrhage—Prednisone—multiple sclerosis	0.000201	0.000939	CcSEcCtD
Mitoxantrone—Erythema—Betamethasone—multiple sclerosis	0.000201	0.000938	CcSEcCtD
Mitoxantrone—Erythema—Dexamethasone—multiple sclerosis	0.000201	0.000938	CcSEcCtD
Mitoxantrone—Malaise—Triamcinolone—multiple sclerosis	0.000199	0.000933	CcSEcCtD
Mitoxantrone—Pancytopenia—Methotrexate—multiple sclerosis	0.000199	0.000931	CcSEcCtD
Mitoxantrone—Malaise—Methylprednisolone—multiple sclerosis	0.000199	0.000931	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000196	0.000918	CcSEcCtD
Mitoxantrone—Oedema—Prednisolone—multiple sclerosis	0.000196	0.000918	CcSEcCtD
Mitoxantrone—Neutropenia—Methotrexate—multiple sclerosis	0.000196	0.000917	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000195	0.000911	CcSEcCtD
Mitoxantrone—Shock—Prednisolone—multiple sclerosis	0.000193	0.000903	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000193	0.000903	CcSEcCtD
Mitoxantrone—Cough—Triamcinolone—multiple sclerosis	0.000193	0.000902	CcSEcCtD
Mitoxantrone—Convulsion—Triamcinolone—multiple sclerosis	0.000192	0.000896	CcSEcCtD
Mitoxantrone—Tachycardia—Prednisolone—multiple sclerosis	0.000192	0.000896	CcSEcCtD
Mitoxantrone—Convulsion—Methylprednisolone—multiple sclerosis	0.000191	0.000894	CcSEcCtD
Mitoxantrone—Hypertension—Triamcinolone—multiple sclerosis	0.000191	0.000893	CcSEcCtD
Mitoxantrone—ABCB1—nervous system—multiple sclerosis	0.000191	0.00541	CbGeAlD
Mitoxantrone—Hypertension—Methylprednisolone—multiple sclerosis	0.000191	0.000891	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00019	0.000887	CcSEcCtD
Mitoxantrone—Myalgia—Triamcinolone—multiple sclerosis	0.000188	0.00088	CcSEcCtD
Mitoxantrone—Vomiting—Azathioprine—multiple sclerosis	0.000188	0.00088	CcSEcCtD
Mitoxantrone—Pneumonia—Methotrexate—multiple sclerosis	0.000188	0.000879	CcSEcCtD
Mitoxantrone—Myalgia—Methylprednisolone—multiple sclerosis	0.000188	0.000878	CcSEcCtD
Mitoxantrone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000188	0.000878	CcSEcCtD
Mitoxantrone—Anxiety—Methylprednisolone—multiple sclerosis	0.000187	0.000875	CcSEcCtD
Mitoxantrone—Drowsiness—Methotrexate—multiple sclerosis	0.000187	0.000874	CcSEcCtD
Mitoxantrone—Rash—Azathioprine—multiple sclerosis	0.000187	0.000873	CcSEcCtD
Mitoxantrone—Dermatitis—Azathioprine—multiple sclerosis	0.000186	0.000872	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000186	0.000871	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000186	0.000871	CcSEcCtD
Mitoxantrone—Discomfort—Triamcinolone—multiple sclerosis	0.000186	0.00087	CcSEcCtD
Mitoxantrone—Discomfort—Methylprednisolone—multiple sclerosis	0.000186	0.000868	CcSEcCtD
Mitoxantrone—Headache—Azathioprine—multiple sclerosis	0.000185	0.000867	CcSEcCtD
Mitoxantrone—ABCB1—central nervous system—multiple sclerosis	0.000184	0.00521	CbGeAlD
Mitoxantrone—Renal failure—Methotrexate—multiple sclerosis	0.000184	0.000859	CcSEcCtD
Mitoxantrone—Stomatitis—Methotrexate—multiple sclerosis	0.000182	0.000852	CcSEcCtD
Mitoxantrone—Conjunctivitis—Methotrexate—multiple sclerosis	0.000182	0.000849	CcSEcCtD
Mitoxantrone—Confusional state—Methylprednisolone—multiple sclerosis	0.000182	0.000849	CcSEcCtD
Mitoxantrone—Malaise—Dexamethasone—multiple sclerosis	0.000181	0.000846	CcSEcCtD
Mitoxantrone—Malaise—Betamethasone—multiple sclerosis	0.000181	0.000846	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000181	0.000844	CcSEcCtD
Mitoxantrone—Oedema—Triamcinolone—multiple sclerosis	0.000181	0.000844	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00018	0.000842	CcSEcCtD
Mitoxantrone—ABCB1—cerebellum—multiple sclerosis	0.00018	0.0051	CbGeAlD
Mitoxantrone—Arrhythmia—Prednisone—multiple sclerosis	0.000179	0.000839	CcSEcCtD
Mitoxantrone—Infection—Triamcinolone—multiple sclerosis	0.000179	0.000839	CcSEcCtD
Mitoxantrone—Sweating—Methotrexate—multiple sclerosis	0.000179	0.000838	CcSEcCtD
Mitoxantrone—Infection—Methylprednisolone—multiple sclerosis	0.000179	0.000837	CcSEcCtD
Mitoxantrone—Haematuria—Methotrexate—multiple sclerosis	0.000178	0.000833	CcSEcCtD
Mitoxantrone—Shock—Triamcinolone—multiple sclerosis	0.000178	0.00083	CcSEcCtD
Mitoxantrone—Alopecia—Prednisone—multiple sclerosis	0.000177	0.00083	CcSEcCtD
Mitoxantrone—Shock—Methylprednisolone—multiple sclerosis	0.000177	0.000829	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisolone—multiple sclerosis	0.000176	0.000824	CcSEcCtD
Mitoxantrone—Tachycardia—Triamcinolone—multiple sclerosis	0.000176	0.000824	CcSEcCtD
Mitoxantrone—Nausea—Azathioprine—multiple sclerosis	0.000176	0.000822	CcSEcCtD
Mitoxantrone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000176	0.000822	CcSEcCtD
Mitoxantrone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000175	0.000818	CcSEcCtD
Mitoxantrone—Erythema—Prednisone—multiple sclerosis	0.000175	0.000817	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000175	0.000816	CcSEcCtD
Mitoxantrone—Agranulocytosis—Methotrexate—multiple sclerosis	0.000174	0.000816	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000174	0.000814	CcSEcCtD
Mitoxantrone—Convulsion—Betamethasone—multiple sclerosis	0.000174	0.000813	CcSEcCtD
Mitoxantrone—Convulsion—Dexamethasone—multiple sclerosis	0.000174	0.000813	CcSEcCtD
Mitoxantrone—Hypertension—Dexamethasone—multiple sclerosis	0.000173	0.00081	CcSEcCtD
Mitoxantrone—Hypertension—Betamethasone—multiple sclerosis	0.000173	0.00081	CcSEcCtD
Mitoxantrone—Myalgia—Betamethasone—multiple sclerosis	0.000171	0.000799	CcSEcCtD
Mitoxantrone—Myalgia—Dexamethasone—multiple sclerosis	0.000171	0.000799	CcSEcCtD
Mitoxantrone—Anxiety—Dexamethasone—multiple sclerosis	0.00017	0.000796	CcSEcCtD
Mitoxantrone—Anxiety—Betamethasone—multiple sclerosis	0.00017	0.000796	CcSEcCtD
Mitoxantrone—Discomfort—Dexamethasone—multiple sclerosis	0.000169	0.000789	CcSEcCtD
Mitoxantrone—Discomfort—Betamethasone—multiple sclerosis	0.000169	0.000789	CcSEcCtD
Mitoxantrone—Haemoglobin—Methotrexate—multiple sclerosis	0.000169	0.000789	CcSEcCtD
Mitoxantrone—Hypotension—Methylprednisolone—multiple sclerosis	0.000168	0.000787	CcSEcCtD
Mitoxantrone—Pain—Prednisolone—multiple sclerosis	0.000168	0.000785	CcSEcCtD
Mitoxantrone—Haemorrhage—Methotrexate—multiple sclerosis	0.000168	0.000785	CcSEcCtD
Mitoxantrone—Hepatitis—Methotrexate—multiple sclerosis	0.000168	0.000785	CcSEcCtD
Mitoxantrone—Pharyngitis—Methotrexate—multiple sclerosis	0.000167	0.000779	CcSEcCtD
Mitoxantrone—Vision blurred—Prednisone—multiple sclerosis	0.000165	0.00077	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000164	0.000769	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000164	0.000767	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000164	0.000766	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000164	0.000766	CcSEcCtD
Mitoxantrone—Oedema—Dexamethasone—multiple sclerosis	0.000164	0.000766	CcSEcCtD
Mitoxantrone—Oedema—Betamethasone—multiple sclerosis	0.000164	0.000766	CcSEcCtD
Mitoxantrone—Infection—Betamethasone—multiple sclerosis	0.000163	0.000761	CcSEcCtD
Mitoxantrone—Infection—Dexamethasone—multiple sclerosis	0.000163	0.000761	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000162	0.000758	CcSEcCtD
Mitoxantrone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000162	0.000758	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000162	0.000756	CcSEcCtD
Mitoxantrone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000162	0.000756	CcSEcCtD
Mitoxantrone—Anaemia—Prednisone—multiple sclerosis	0.000162	0.000755	CcSEcCtD
Mitoxantrone—Shock—Dexamethasone—multiple sclerosis	0.000161	0.000753	CcSEcCtD
Mitoxantrone—Shock—Betamethasone—multiple sclerosis	0.000161	0.000753	CcSEcCtD
Mitoxantrone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000161	0.000752	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00016	0.00075	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00016	0.00075	CcSEcCtD
Mitoxantrone—Tachycardia—Betamethasone—multiple sclerosis	0.00016	0.000747	CcSEcCtD
Mitoxantrone—Tachycardia—Dexamethasone—multiple sclerosis	0.00016	0.000747	CcSEcCtD
Mitoxantrone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000159	0.000743	CcSEcCtD
Mitoxantrone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000159	0.000741	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000158	0.00074	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000158	0.00074	CcSEcCtD
Mitoxantrone—Malaise—Prednisone—multiple sclerosis	0.000158	0.000737	CcSEcCtD
Mitoxantrone—Anorexia—Dexamethasone—multiple sclerosis	0.000156	0.00073	CcSEcCtD
Mitoxantrone—Anorexia—Betamethasone—multiple sclerosis	0.000156	0.00073	CcSEcCtD
Mitoxantrone—Urticaria—Prednisolone—multiple sclerosis	0.000156	0.000729	CcSEcCtD
Mitoxantrone—Fatigue—Triamcinolone—multiple sclerosis	0.000156	0.000728	CcSEcCtD
Mitoxantrone—Fatigue—Methylprednisolone—multiple sclerosis	0.000155	0.000726	CcSEcCtD
Mitoxantrone—Pain—Triamcinolone—multiple sclerosis	0.000154	0.000722	CcSEcCtD
Mitoxantrone—CYP1B1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000153	0.00139	CbGpPWpGaD
Mitoxantrone—Hypotension—Dexamethasone—multiple sclerosis	0.000153	0.000716	CcSEcCtD
Mitoxantrone—Hypotension—Betamethasone—multiple sclerosis	0.000153	0.000716	CcSEcCtD
Mitoxantrone—Convulsion—Prednisone—multiple sclerosis	0.000151	0.000708	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000151	0.00136	CbGpPWpGaD
Mitoxantrone—Hypertension—Prednisone—multiple sclerosis	0.000151	0.000706	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—multiple sclerosis	0.000151	0.000704	CcSEcCtD
Mitoxantrone—BTK—Immune System—PDCD1—multiple sclerosis	0.00015	0.00136	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000149	0.000698	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000149	0.000698	CcSEcCtD
Mitoxantrone—Arthralgia—Prednisone—multiple sclerosis	0.000149	0.000696	CcSEcCtD
Mitoxantrone—Myalgia—Prednisone—multiple sclerosis	0.000149	0.000696	CcSEcCtD
Mitoxantrone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000149	0.000696	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000148	0.000694	CcSEcCtD
Mitoxantrone—Anxiety—Prednisone—multiple sclerosis	0.000148	0.000693	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—multiple sclerosis	0.000148	0.000693	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—MAPK1—multiple sclerosis	0.000148	0.00134	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000147	0.000689	CcSEcCtD
Mitoxantrone—BTK—Immune System—IL7R—multiple sclerosis	0.000147	0.00133	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000147	0.00133	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Betamethasone—multiple sclerosis	0.000147	0.000688	CcSEcCtD
Mitoxantrone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000147	0.000688	CcSEcCtD
Mitoxantrone—Discomfort—Prednisone—multiple sclerosis	0.000147	0.000687	CcSEcCtD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000147	0.00132	CbGpPWpGaD
Mitoxantrone—Erythema—Methotrexate—multiple sclerosis	0.000146	0.000683	CcSEcCtD
Mitoxantrone—ABCB1—brain—multiple sclerosis	0.000146	0.00414	CbGeAlD
Mitoxantrone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000145	0.000676	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000145	0.00131	CbGpPWpGaD
Mitoxantrone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000144	0.000674	CcSEcCtD
Mitoxantrone—Dyspepsia—Betamethasone—multiple sclerosis	0.000144	0.000674	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000144	0.0013	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000144	0.0013	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CD28—multiple sclerosis	0.000144	0.0013	CbGpPWpGaD
Mitoxantrone—Urticaria—Triamcinolone—multiple sclerosis	0.000143	0.000671	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000143	0.0013	CbGpPWpGaD
Mitoxantrone—Urticaria—Methylprednisolone—multiple sclerosis	0.000143	0.000669	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—multiple sclerosis	0.000143	0.000669	CcSEcCtD
Mitoxantrone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000143	0.000667	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000143	0.000667	CcSEcCtD
Mitoxantrone—Oedema—Prednisone—multiple sclerosis	0.000143	0.000667	CcSEcCtD
Mitoxantrone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000142	0.000666	CcSEcCtD
Mitoxantrone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000142	0.000666	CcSEcCtD
Mitoxantrone—Decreased appetite—Betamethasone—multiple sclerosis	0.000142	0.000666	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000142	0.00128	CbGpPWpGaD
Mitoxantrone—Infection—Prednisone—multiple sclerosis	0.000142	0.000663	CcSEcCtD
Mitoxantrone—Back pain—Methotrexate—multiple sclerosis	0.000141	0.000661	CcSEcCtD
Mitoxantrone—Fatigue—Betamethasone—multiple sclerosis	0.000141	0.00066	CcSEcCtD
Mitoxantrone—Fatigue—Dexamethasone—multiple sclerosis	0.000141	0.00066	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—CCR2—multiple sclerosis	0.000141	0.00128	CbGpPWpGaD
Mitoxantrone—Shock—Prednisone—multiple sclerosis	0.00014	0.000656	CcSEcCtD
Mitoxantrone—Pain—Betamethasone—multiple sclerosis	0.00014	0.000655	CcSEcCtD
Mitoxantrone—Pain—Dexamethasone—multiple sclerosis	0.00014	0.000655	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—MAPK1—multiple sclerosis	0.000139	0.00126	CbGpPWpGaD
Mitoxantrone—Tachycardia—Prednisone—multiple sclerosis	0.000139	0.000651	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000139	0.00126	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000139	0.00126	CbGpPWpGaD
Mitoxantrone—Skin disorder—Prednisone—multiple sclerosis	0.000139	0.000648	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—CD28—multiple sclerosis	0.000138	0.00125	CbGpPWpGaD
Mitoxantrone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000138	0.000645	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000138	0.00125	CbGpPWpGaD
Mitoxantrone—Vision blurred—Methotrexate—multiple sclerosis	0.000138	0.000644	CcSEcCtD
Mitoxantrone—TOP2A—Circadian rythm related genes—FAS—multiple sclerosis	0.000136	0.00123	CbGpPWpGaD
Mitoxantrone—Anorexia—Prednisone—multiple sclerosis	0.000136	0.000636	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000136	0.00123	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PTPRC—multiple sclerosis	0.000136	0.00123	CbGpPWpGaD
Mitoxantrone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000136	0.000634	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000135	0.00122	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CBLB—multiple sclerosis	0.000135	0.00122	CbGpPWpGaD
Mitoxantrone—Anaemia—Methotrexate—multiple sclerosis	0.000135	0.000631	CcSEcCtD
Mitoxantrone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000135	0.000631	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000135	0.000631	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000135	0.00122	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000134	0.000626	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000134	0.000626	CcSEcCtD
Mitoxantrone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000133	0.000622	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000133	0.00062	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000132	0.0012	CbGpPWpGaD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—IL6—multiple sclerosis	0.000132	0.00119	CbGpPWpGaD
Mitoxantrone—Malaise—Methotrexate—multiple sclerosis	0.000132	0.000616	CcSEcCtD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000131	0.00119	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-DPB1—multiple sclerosis	0.000131	0.00118	CbGpPWpGaD
Mitoxantrone—Leukopenia—Methotrexate—multiple sclerosis	0.000131	0.000611	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—IFNB1—multiple sclerosis	0.00013	0.00118	CbGpPWpGaD
Mitoxantrone—Urticaria—Betamethasone—multiple sclerosis	0.00013	0.000608	CcSEcCtD
Mitoxantrone—Urticaria—Dexamethasone—multiple sclerosis	0.00013	0.000608	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00013	0.000608	CcSEcCtD
Mitoxantrone—Asthenia—Triamcinolone—multiple sclerosis	0.00013	0.000606	CcSEcCtD
Mitoxantrone—Body temperature increased—Betamethasone—multiple sclerosis	0.000129	0.000605	CcSEcCtD
Mitoxantrone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000129	0.000605	CcSEcCtD
Mitoxantrone—Abdominal pain—Betamethasone—multiple sclerosis	0.000129	0.000605	CcSEcCtD
Mitoxantrone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000129	0.000605	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000129	0.00117	CbGpPWpGaD
Mitoxantrone—Asthenia—Methylprednisolone—multiple sclerosis	0.000129	0.000604	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisone—multiple sclerosis	0.000128	0.000599	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—multiple sclerosis	0.000127	0.000596	CcSEcCtD
Mitoxantrone—Convulsion—Methotrexate—multiple sclerosis	0.000127	0.000592	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000126	0.00114	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000126	0.00114	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD40—multiple sclerosis	0.000126	0.00114	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ITGA4—multiple sclerosis	0.000126	0.00114	CbGpPWpGaD
Mitoxantrone—Dyspepsia—Prednisone—multiple sclerosis	0.000126	0.000587	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	0.000126	0.00113	CbGpPWpGaD
Mitoxantrone—Myalgia—Methotrexate—multiple sclerosis	0.000124	0.000581	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—multiple sclerosis	0.000124	0.000581	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—multiple sclerosis	0.000124	0.000581	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—CTLA4—multiple sclerosis	0.000124	0.00112	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000124	0.00112	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.000124	0.00112	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Prednisone—multiple sclerosis	0.000124	0.00058	CcSEcCtD
Mitoxantrone—Rash—Prednisolone—multiple sclerosis	0.000124	0.000579	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisolone—multiple sclerosis	0.000124	0.000578	CcSEcCtD
Mitoxantrone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000124	0.00112	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000123	0.000576	CcSEcCtD
Mitoxantrone—Fatigue—Prednisone—multiple sclerosis	0.000123	0.000575	CcSEcCtD
Mitoxantrone—Headache—Prednisolone—multiple sclerosis	0.000123	0.000575	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—multiple sclerosis	0.000123	0.000574	CcSEcCtD
Mitoxantrone—Constipation—Prednisone—multiple sclerosis	0.000122	0.00057	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	0.000121	0.0011	CbGpPWpGaD
Mitoxantrone—Confusional state—Methotrexate—multiple sclerosis	0.00012	0.000562	CcSEcCtD
Mitoxantrone—BTK—Immune System—MX1—multiple sclerosis	0.00012	0.00108	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.00012	0.00108	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	0.00012	0.00108	CbGpPWpGaD
Mitoxantrone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000119	0.000557	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—multiple sclerosis	0.000118	0.000554	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisone—multiple sclerosis	0.000118	0.00055	CcSEcCtD
Mitoxantrone—Asthenia—Betamethasone—multiple sclerosis	0.000118	0.000549	CcSEcCtD
Mitoxantrone—Asthenia—Dexamethasone—multiple sclerosis	0.000118	0.000549	CcSEcCtD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000117	0.00106	CbGpPWpGaD
Mitoxantrone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000117	0.000546	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000117	0.000545	CcSEcCtD
Mitoxantrone—Nausea—Prednisolone—multiple sclerosis	0.000117	0.000545	CcSEcCtD
Mitoxantrone—BTK—Immune System—HLA-DRA—multiple sclerosis	0.000116	0.00105	CbGpPWpGaD
Mitoxantrone—Skin disorder—Methotrexate—multiple sclerosis	0.000116	0.000541	CcSEcCtD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000116	0.00104	CbGpPWpGaD
Mitoxantrone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000115	0.000539	CcSEcCtD
Mitoxantrone—Vomiting—Triamcinolone—multiple sclerosis	0.000115	0.000537	CcSEcCtD
Mitoxantrone—Vomiting—Methylprednisolone—multiple sclerosis	0.000115	0.000535	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—IL6—multiple sclerosis	0.000114	0.00103	CbGpPWpGaD
Mitoxantrone—Rash—Triamcinolone—multiple sclerosis	0.000114	0.000532	CcSEcCtD
Mitoxantrone—Dermatitis—Triamcinolone—multiple sclerosis	0.000114	0.000532	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—multiple sclerosis	0.000114	0.000531	CcSEcCtD
Mitoxantrone—Rash—Methylprednisolone—multiple sclerosis	0.000114	0.000531	CcSEcCtD
Mitoxantrone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000113	0.000531	CcSEcCtD
Mitoxantrone—Urticaria—Prednisone—multiple sclerosis	0.000113	0.00053	CcSEcCtD
Mitoxantrone—Headache—Triamcinolone—multiple sclerosis	0.000113	0.000529	CcSEcCtD
Mitoxantrone—Headache—Methylprednisolone—multiple sclerosis	0.000113	0.000528	CcSEcCtD
Mitoxantrone—Abdominal pain—Prednisone—multiple sclerosis	0.000113	0.000527	CcSEcCtD
Mitoxantrone—Body temperature increased—Prednisone—multiple sclerosis	0.000113	0.000527	CcSEcCtD
Mitoxantrone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000112	0.000524	CcSEcCtD
Mitoxantrone—Diarrhoea—Betamethasone—multiple sclerosis	0.000112	0.000524	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000112	0.00101	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000111	0.00101	CbGpPWpGaD
Mitoxantrone—Hypotension—Methotrexate—multiple sclerosis	0.000111	0.000521	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—MAPK1—multiple sclerosis	0.00011	0.000994	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.00011	0.000992	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.00011	0.000992	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—VCAM1—multiple sclerosis	0.00011	0.000991	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NOD1—multiple sclerosis	0.000109	0.000989	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-DQA1—multiple sclerosis	0.000109	0.000988	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000109	0.000508	CcSEcCtD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000108	0.000979	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000108	0.000979	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000108	0.000974	CbGpPWpGaD
Mitoxantrone—Nausea—Triamcinolone—multiple sclerosis	0.000107	0.000501	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—IL6—multiple sclerosis	0.000107	0.000968	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Methotrexate—multiple sclerosis	0.000107	0.000501	CcSEcCtD
Mitoxantrone—Nausea—Methylprednisolone—multiple sclerosis	0.000107	0.0005	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—multiple sclerosis	0.000106	0.000497	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—multiple sclerosis	0.000106	0.000496	CcSEcCtD
Mitoxantrone—BTK—Immune System—MALT1—multiple sclerosis	0.000106	0.000955	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000106	0.000955	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000106	0.000955	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Prednisone—multiple sclerosis	0.000105	0.000491	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—multiple sclerosis	0.000105	0.000491	CcSEcCtD
Mitoxantrone—Vomiting—Betamethasone—multiple sclerosis	0.000104	0.000487	CcSEcCtD
Mitoxantrone—Vomiting—Dexamethasone—multiple sclerosis	0.000104	0.000487	CcSEcCtD
Mitoxantrone—BTK—Immune System—IRF5—multiple sclerosis	0.000104	0.00094	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Methotrexate—multiple sclerosis	0.000104	0.000485	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—MAPK1—multiple sclerosis	0.000103	0.000935	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—MAPK1—multiple sclerosis	0.000103	0.000935	CbGpPWpGaD
Mitoxantrone—Rash—Dexamethasone—multiple sclerosis	0.000103	0.000483	CcSEcCtD
Mitoxantrone—Rash—Betamethasone—multiple sclerosis	0.000103	0.000483	CcSEcCtD
Mitoxantrone—Dermatitis—Dexamethasone—multiple sclerosis	0.000103	0.000482	CcSEcCtD
Mitoxantrone—Dermatitis—Betamethasone—multiple sclerosis	0.000103	0.000482	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000103	0.000929	CbGpPWpGaD
Mitoxantrone—Fatigue—Methotrexate—multiple sclerosis	0.000103	0.000481	CcSEcCtD
Mitoxantrone—Headache—Betamethasone—multiple sclerosis	0.000103	0.00048	CcSEcCtD
Mitoxantrone—Headache—Dexamethasone—multiple sclerosis	0.000103	0.00048	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—CD86—multiple sclerosis	0.000103	0.000927	CbGpPWpGaD
Mitoxantrone—Asthenia—Prednisone—multiple sclerosis	0.000102	0.000479	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—HLA-DQB1—multiple sclerosis	0.000102	0.000924	CbGpPWpGaD
Mitoxantrone—Pain—Methotrexate—multiple sclerosis	0.000102	0.000477	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000101	0.000908	CbGpPWpGaD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.0001	0.000906	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFIH1—multiple sclerosis	9.94e-05	0.000898	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IRF8—multiple sclerosis	9.94e-05	0.000898	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-G—multiple sclerosis	9.94e-05	0.000898	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD86—multiple sclerosis	9.85e-05	0.00089	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Methotrexate—multiple sclerosis	9.82e-05	0.000459	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.81e-05	0.000887	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Prednisone—multiple sclerosis	9.76e-05	0.000456	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.75e-05	0.000456	CcSEcCtD
Mitoxantrone—Nausea—Betamethasone—multiple sclerosis	9.73e-05	0.000455	CcSEcCtD
Mitoxantrone—Nausea—Dexamethasone—multiple sclerosis	9.73e-05	0.000455	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—CD40LG—multiple sclerosis	9.66e-05	0.000873	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	9.65e-05	0.000872	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HLA-B—multiple sclerosis	9.57e-05	0.000865	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD8A—multiple sclerosis	9.55e-05	0.000863	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—IL6—multiple sclerosis	9.54e-05	0.000862	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	9.47e-05	0.000856	CbGpPWpGaD
Mitoxantrone—Urticaria—Methotrexate—multiple sclerosis	9.47e-05	0.000443	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—multiple sclerosis	9.42e-05	0.000441	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—multiple sclerosis	9.42e-05	0.000441	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	9.42e-05	0.000851	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	9.31e-05	0.000842	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TNFAIP3—multiple sclerosis	9.31e-05	0.000841	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-B—multiple sclerosis	9.19e-05	0.00083	CbGpPWpGaD
Mitoxantrone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	9.13e-05	0.000825	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SRM—multiple sclerosis	9.09e-05	0.000822	CbGpPWpGaD
Mitoxantrone—Vomiting—Prednisone—multiple sclerosis	9.07e-05	0.000424	CcSEcCtD
Mitoxantrone—Rash—Prednisone—multiple sclerosis	8.99e-05	0.000421	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisone—multiple sclerosis	8.99e-05	0.00042	CcSEcCtD
Mitoxantrone—Headache—Prednisone—multiple sclerosis	8.94e-05	0.000418	CcSEcCtD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.81e-05	0.000796	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SRM—multiple sclerosis	8.79e-05	0.000795	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Methotrexate—multiple sclerosis	8.78e-05	0.000411	CcSEcCtD
Mitoxantrone—Asthenia—Methotrexate—multiple sclerosis	8.55e-05	0.0004	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—MYC—multiple sclerosis	8.54e-05	0.000772	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-A—multiple sclerosis	8.51e-05	0.000769	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	8.51e-05	0.000769	CbGpPWpGaD
Mitoxantrone—Nausea—Prednisone—multiple sclerosis	8.47e-05	0.000396	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—IL6—multiple sclerosis	8.45e-05	0.000764	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD28—multiple sclerosis	8.37e-05	0.000757	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTPRC—multiple sclerosis	8.22e-05	0.000743	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CCR2—multiple sclerosis	8.22e-05	0.000743	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Methotrexate—multiple sclerosis	8.16e-05	0.000381	CcSEcCtD
Mitoxantrone—CYP1B1—Biological oxidations—POMC—multiple sclerosis	8.15e-05	0.000736	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TLR4—multiple sclerosis	8.11e-05	0.000733	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SRM—multiple sclerosis	8e-05	0.000723	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	7.95e-05	0.000719	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—IL6—multiple sclerosis	7.95e-05	0.000719	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-DPB1—multiple sclerosis	7.95e-05	0.000718	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	7.86e-05	0.00071	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.79e-05	0.000704	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-DRB1—multiple sclerosis	7.78e-05	0.000703	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.75e-05	0.000701	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD40—multiple sclerosis	7.64e-05	0.000691	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ITGA4—multiple sclerosis	7.64e-05	0.000691	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFNB1—multiple sclerosis	7.59e-05	0.000686	CbGpPWpGaD
Mitoxantrone—Vomiting—Methotrexate—multiple sclerosis	7.58e-05	0.000354	CcSEcCtD
Mitoxantrone—BTK—Immune System—CTLA4—multiple sclerosis	7.53e-05	0.000681	CbGpPWpGaD
Mitoxantrone—Rash—Methotrexate—multiple sclerosis	7.52e-05	0.000351	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—multiple sclerosis	7.51e-05	0.000351	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—CD80—multiple sclerosis	7.48e-05	0.000676	CbGpPWpGaD
Mitoxantrone—Headache—Methotrexate—multiple sclerosis	7.47e-05	0.000349	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—ICAM1—multiple sclerosis	7.46e-05	0.000675	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.45e-05	0.000673	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD80—multiple sclerosis	7.19e-05	0.000649	CbGpPWpGaD
Mitoxantrone—Nausea—Methotrexate—multiple sclerosis	7.08e-05	0.000331	CcSEcCtD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7e-05	0.000632	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GPC5—multiple sclerosis	7e-05	0.000632	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.85e-05	0.00062	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.8e-05	0.000615	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—VCAM1—multiple sclerosis	6.65e-05	0.000601	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-DQA1—multiple sclerosis	6.63e-05	0.000599	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.47e-05	0.000585	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.46e-05	0.000583	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP24A1—multiple sclerosis	6.41e-05	0.000579	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP27B1—multiple sclerosis	6.41e-05	0.000579	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.33e-05	0.000572	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.33e-05	0.000572	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TYK2—multiple sclerosis	6.32e-05	0.000571	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.26e-05	0.000566	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.21e-05	0.000562	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-DQB1—multiple sclerosis	6.2e-05	0.000561	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP27B1—multiple sclerosis	6.2e-05	0.00056	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP24A1—multiple sclerosis	6.2e-05	0.00056	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.06e-05	0.000547	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.03e-05	0.000545	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD86—multiple sclerosis	5.97e-05	0.00054	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GPC5—multiple sclerosis	5.86e-05	0.000529	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD40LG—multiple sclerosis	5.86e-05	0.000529	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD8A—multiple sclerosis	5.79e-05	0.000524	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SRM—multiple sclerosis	5.74e-05	0.000519	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.73e-05	0.000518	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CD4—multiple sclerosis	5.71e-05	0.000516	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GPC5—multiple sclerosis	5.67e-05	0.000512	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP27B1—multiple sclerosis	5.64e-05	0.000509	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP24A1—multiple sclerosis	5.64e-05	0.000509	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-B—multiple sclerosis	5.57e-05	0.000504	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.54e-05	0.000501	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.52e-05	0.000499	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD4—multiple sclerosis	5.49e-05	0.000496	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.46e-05	0.000494	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—POMC—multiple sclerosis	5.32e-05	0.000481	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.3e-05	0.000479	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2RA—multiple sclerosis	5.22e-05	0.000472	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-A—multiple sclerosis	5.16e-05	0.000467	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPC5—multiple sclerosis	5.16e-05	0.000466	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—RRM1—multiple sclerosis	4.85e-05	0.000439	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR4—multiple sclerosis	4.72e-05	0.000427	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-DRB1—multiple sclerosis	4.72e-05	0.000426	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—RRM1—multiple sclerosis	4.7e-05	0.000424	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.68e-05	0.000423	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	4.67e-05	0.000422	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.65e-05	0.00042	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RPL5—multiple sclerosis	4.55e-05	0.000411	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ICAM1—multiple sclerosis	4.53e-05	0.000409	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD80—multiple sclerosis	4.36e-05	0.000394	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC11A1—multiple sclerosis	4.36e-05	0.000394	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SRM—multiple sclerosis	4.33e-05	0.000391	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.31e-05	0.000389	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—RRM1—multiple sclerosis	4.27e-05	0.000386	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.19e-05	0.000379	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	4.05e-05	0.000366	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	4.05e-05	0.000366	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.02e-05	0.000363	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MAPK1—multiple sclerosis	4.02e-05	0.000363	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.77e-05	0.00034	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.71e-05	0.000335	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.7e-05	0.000334	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TYK2—multiple sclerosis	3.68e-05	0.000332	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.64e-05	0.000329	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD28—multiple sclerosis	3.48e-05	0.000314	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFNG—multiple sclerosis	3.44e-05	0.000311	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD4—multiple sclerosis	3.33e-05	0.000301	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.24e-05	0.000292	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	3.13e-05	0.000283	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.13e-05	0.000283	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—multiple sclerosis	3.09e-05	0.000279	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—multiple sclerosis	3.07e-05	0.000278	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.07e-05	0.000277	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	3.06e-05	0.000277	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—multiple sclerosis	3.06e-05	0.000277	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.05e-05	0.000275	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.05e-05	0.000275	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.95e-05	0.000267	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.85e-05	0.000258	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.8e-05	0.000253	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—multiple sclerosis	2.8e-05	0.000253	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—BCHE—multiple sclerosis	2.79e-05	0.000252	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPC5—multiple sclerosis	2.79e-05	0.000252	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	2.74e-05	0.000248	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—BCHE—multiple sclerosis	2.7e-05	0.000244	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SRM—multiple sclerosis	2.66e-05	0.000241	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—multiple sclerosis	2.58e-05	0.000233	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD86—multiple sclerosis	2.48e-05	0.000224	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.47e-05	0.000223	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.47e-05	0.000223	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—BCHE—multiple sclerosis	2.45e-05	0.000222	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK1—multiple sclerosis	2.34e-05	0.000212	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RRM1—multiple sclerosis	2.31e-05	0.000209	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CCR5—multiple sclerosis	2.2e-05	0.000199	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HLA-A—multiple sclerosis	2.15e-05	0.000194	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.13e-05	0.000193	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.13e-05	0.000192	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.08e-05	0.000188	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—multiple sclerosis	2e-05	0.000181	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.98e-05	0.000179	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.88e-05	0.00017	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.88e-05	0.00017	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD80—multiple sclerosis	1.81e-05	0.000164	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—multiple sclerosis	1.8e-05	0.000163	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.76e-05	0.000159	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.72e-05	0.000155	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—multiple sclerosis	1.68e-05	0.000152	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—multiple sclerosis	1.62e-05	0.000147	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TYK2—multiple sclerosis	1.53e-05	0.000138	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—multiple sclerosis	1.48e-05	0.000133	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POMC—multiple sclerosis	1.44e-05	0.00013	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.42e-05	0.000129	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POMC—multiple sclerosis	1.39e-05	0.000126	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—multiple sclerosis	1.38e-05	0.000125	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.33e-05	0.000121	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.00012	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—multiple sclerosis	1.31e-05	0.000119	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—multiple sclerosis	1.27e-05	0.000115	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POMC—multiple sclerosis	1.27e-05	0.000115	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—multiple sclerosis	1.16e-05	0.000104	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—multiple sclerosis	1.07e-05	9.67e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—multiple sclerosis	1.06e-05	9.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—multiple sclerosis	9.95e-06	8.99e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—multiple sclerosis	9.92e-06	8.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK1—multiple sclerosis	9.73e-06	8.79e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POMC—multiple sclerosis	9.1e-06	8.23e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—multiple sclerosis	8.3e-06	7.5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.17e-06	7.39e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—multiple sclerosis	7.98e-06	7.21e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—multiple sclerosis	7.48e-06	6.76e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POMC—multiple sclerosis	6.85e-06	6.2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—multiple sclerosis	6.25e-06	5.65e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—multiple sclerosis	4.92e-06	4.44e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POMC—multiple sclerosis	4.22e-06	3.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.85e-06	3.48e-05	CbGpPWpGaD
